tividenofusp alfa-eknm 150 MG Injection [Avlayah]
- RxCUI
- 2740025
- RxNorm name
- tividenofusp alfa-eknm 150 MG Injection [Avlayah]
- Display name
- tividenofusp alfa-eknm 150 MG Injection [Avlayah]
- Full name
- tividenofusp alfa-eknm 150 MG Injection [Avlayah]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:45
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761485 | Avlayah | tividenofusp alfa-eknm | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AVLAYAH | TIVIDENOFUSP ALFA-EKNM | Denali Therapeutics Inc. | 014d92c1-b643-4680-8ca6-f0b3307da915 | 2026-03-20 | Boxed warning, Warnings, Adverse reactions | 2740025 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 014d92c1-b643-4680-8ca6-f0b3307da915 | tividenofusp alfa-eknm 150 MG Injection [Avlayah] | SBD | 2 | These highlights do not include all the information needed to use AVLAYAH™ safely and effectively. See full prescribing information for AVLAYAH. AVLAYAH (tividenofusp alfa-eknm) for injection, for intravenous use Initial U.S. Approval: 2026 | 20260320 |
| 014d92c1-b643-4680-8ca6-f0b3307da915 | AVLAYAH 150 MG Injection | PSN | 2 | These highlights do not include all the information needed to use AVLAYAH™ safely and effectively. See full prescribing information for AVLAYAH. AVLAYAH (tividenofusp alfa-eknm) for injection, for intravenous use Initial U.S. Approval: 2026 | 20260320 |
| 014d92c1-b643-4680-8ca6-f0b3307da915 | Avlayah 150 MG Injection | SY | 2 | These highlights do not include all the information needed to use AVLAYAH™ safely and effectively. See full prescribing information for AVLAYAH. AVLAYAH (tividenofusp alfa-eknm) for injection, for intravenous use Initial U.S. Approval: 2026 | 20260320 |